Cargando…
Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
Enzymes AKR1C regulate the action of oestrogens, androgens, and progesterone at the pre-receptor level and are also associated with chemo-resistance. The activities of these oestrone halides were investigated on recombinant AKR1C enzymes. The oestrone halides with halogen atoms at both C-2 and C-4 p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266253/ https://www.ncbi.nlm.nih.gov/pubmed/34227437 http://dx.doi.org/10.1080/14756366.2021.1937142 |
_version_ | 1783719906627289088 |
---|---|
author | Sinreih, Maša Jójárt, Rebeka Kele, Zoltán Büdefeld, Tomaž Paragi, Gábor Mernyák, Erzsébet Rižner, Tea Lanišnik |
author_facet | Sinreih, Maša Jójárt, Rebeka Kele, Zoltán Büdefeld, Tomaž Paragi, Gábor Mernyák, Erzsébet Rižner, Tea Lanišnik |
author_sort | Sinreih, Maša |
collection | PubMed |
description | Enzymes AKR1C regulate the action of oestrogens, androgens, and progesterone at the pre-receptor level and are also associated with chemo-resistance. The activities of these oestrone halides were investigated on recombinant AKR1C enzymes. The oestrone halides with halogen atoms at both C-2 and C-4 positions (13β-, 13α-methyl-17-keto halogen derivatives) were the most potent inhibitors of AKR1C1. The lowest IC(50) values were for the 13α-epimers 2_2I,4Br and 2_2I,4Cl (IC(50), 0.7 μM, 0.8 μM, respectively), both of which selectively inhibited the AKR1C1 isoform. The 13α-methyl-17-keto halogen derivatives 2_2Br and 2_4Cl were the most potent inhibitors of AKR1C2 (IC(50), 1.5 μM, 1.8 μM, respectively), with high selectivity for the AKR1C2 isoform. Compound 1_2Cl,4Cl showed the best AKR1C3 inhibition, and it also inhibited AKR1C1 (Ki: AKR1C1, 0.69 μM; AKR1C3, 1.43 μM). These data show that halogenated derivatives of oestrone represent a new class of potent and selective AKR1C inhibitors as lead compounds for further optimisations. |
format | Online Article Text |
id | pubmed-8266253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-82662532021-07-19 Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives Sinreih, Maša Jójárt, Rebeka Kele, Zoltán Büdefeld, Tomaž Paragi, Gábor Mernyák, Erzsébet Rižner, Tea Lanišnik J Enzyme Inhib Med Chem Research Paper Enzymes AKR1C regulate the action of oestrogens, androgens, and progesterone at the pre-receptor level and are also associated with chemo-resistance. The activities of these oestrone halides were investigated on recombinant AKR1C enzymes. The oestrone halides with halogen atoms at both C-2 and C-4 positions (13β-, 13α-methyl-17-keto halogen derivatives) were the most potent inhibitors of AKR1C1. The lowest IC(50) values were for the 13α-epimers 2_2I,4Br and 2_2I,4Cl (IC(50), 0.7 μM, 0.8 μM, respectively), both of which selectively inhibited the AKR1C1 isoform. The 13α-methyl-17-keto halogen derivatives 2_2Br and 2_4Cl were the most potent inhibitors of AKR1C2 (IC(50), 1.5 μM, 1.8 μM, respectively), with high selectivity for the AKR1C2 isoform. Compound 1_2Cl,4Cl showed the best AKR1C3 inhibition, and it also inhibited AKR1C1 (Ki: AKR1C1, 0.69 μM; AKR1C3, 1.43 μM). These data show that halogenated derivatives of oestrone represent a new class of potent and selective AKR1C inhibitors as lead compounds for further optimisations. Taylor & Francis 2021-07-06 /pmc/articles/PMC8266253/ /pubmed/34227437 http://dx.doi.org/10.1080/14756366.2021.1937142 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Sinreih, Maša Jójárt, Rebeka Kele, Zoltán Büdefeld, Tomaž Paragi, Gábor Mernyák, Erzsébet Rižner, Tea Lanišnik Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives |
title | Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives |
title_full | Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives |
title_fullStr | Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives |
title_full_unstemmed | Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives |
title_short | Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives |
title_sort | synthesis and evaluation of akr1c inhibitory properties of a-ring halogenated oestrone derivatives |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266253/ https://www.ncbi.nlm.nih.gov/pubmed/34227437 http://dx.doi.org/10.1080/14756366.2021.1937142 |
work_keys_str_mv | AT sinreihmasa synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives AT jojartrebeka synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives AT kelezoltan synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives AT budefeldtomaz synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives AT paragigabor synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives AT mernyakerzsebet synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives AT riznertealanisnik synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives |